Drug delivery to brain by microparticulate systems

Advances in Experimental Medicine and Biology

Volumn 553, Issue , 2004, Pages 221-230

  Kaş, H Süheyla ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETHANECHOL; BROMOCRIPTINE MESILATE; CARBIDOPA; CARBOPLATIN; CARMUSTINE; CHITOSAN; DEXAMETHASONE; DIMETICONE; DOPAMINE; DOXORUBICIN; DRUG CARRIER; ETOPOSIDE; FLUOROURACIL; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE]; LEVODOPA; LIPOSOME; LOPERAMIDE; METHOTREXATE; MICROSPHERE; MITOMYCIN; NANOPARTICLE; NERVE GROWTH FACTOR; NIMUSTINE; OXANTHRAZOLE; POLY(METHYL METHACRYLATE); POLYGLACTIN; POLYLACTIC ACID; POLYMER; TUBOCURARINE CHLORIDE; UNINDEXED DRUG;

BIODEGRADABLE IMPLANT; BLOOD BRAIN BARRIER; BRAIN; CELL STRAIN; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRUG IMPLANT; DRUG PELLET; DRUG PENETRATION; DRUG TRANSPORT; HUMAN; MICROPARTICULATE SYSTEM; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL;

EID: 6344278521     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-306-48584-8_17     Document Type: Conference Paper

References (38)

1. Brightman, M.W., 1997, Morphology of blood-brain interface. Exp. Eye Res. 25: 1-25.
2. Partridge, W.M., 1996, Brain drug delivery and blood-brain barrier transport. Drug Delivery 3: 99-115.
3. Partridge, W.M., 1999, Vector mediated drug delivery to the brain. Adv. Del. Reviews 36: 299-321
4. Kubo, O., Tajika, Y., Muragaki, Y., 1994, Local chemotherapy with slow releasing anticancer drug-polymers for malignant brain tumors. J. Cont. Rel. 32: 1-8.
5. Menei, P, Boisdron-Celle, M, Croue, A., 1996, Effect of stereotaxic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. Neurusurgery 39: 117-124.
6. Chandy, T., Das, G.S., Rao, G.H.R., 2000, 5-Fluorouracil loaded polylactic acid microspheres as biodegradable drug carrier for cerebral tumors, J. Microencapsulation 17: 625-638.
7. Menei, P., Venier-Julienne, M.C., Benoit, J.P., 1997, Drug delivery into the brain using implantable polymeric systems. S.T.P. Pharma Sci. 7: 53-61.
8. Painbeni, T., Venier-Julienne, M.C., Benoit, J.P., 1998, Internal morphology of poly (D,L-lactide-co-glycolide) BCNU-loaded microspheres: Influence on drug stabiliy. Eur. J. Pharm. Biopham. 45: 31-39.
9. Valtonen, S., Timonen, U., Tolvanen, P., 1997, Interstitial chemotherapy with carmustin loaded polymers for high grade gliomas: A randomized double-blind study. Neurosurgery 41: 44-48.
10. Langer, R., 1990, New methods of drug delivery. Science 249: 1527-1533.
11. Hassan, E.E. and Gallo, J.M., 1993, Targeting anticancer to the brain. I. Enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres. J. Drug Targeting 1: 7-14.
12. Kreuter, J., 1998, Recent advances in nanoparticles and nanospheres. In Biomedical Science and Technology (A.A. Hincal and H.S. Kas, eds.) Plenum Press, NY, pp. 31-39.
13. Brigger, L., Morizet, J., Aubert, G., Chacun, H., Terrier-Lacombe, M.J., Couvreur, P., Vassal, G., 2002, Poly (ethylene glycol) coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. J. Pharm. Exp. Therapeutics 303: 928-936.
14. Zhou, R., Mazurchuk, R., Straubinger, R.M., 2002, Antivasculature effects of doxorubicin containing liposomes in an intracranial rat brain tumor model. Cancer Res. 62: 2561-2566.
15. R) in glioblastomas and metastatic brain tumors. British J. Cancer 86: 660-661.
16. Chen, W. and Lu, D.R., 1999, Carboplatin loaded PLGA microspheres for intracerebral injection: formulation and characterisation. J. Microencapsulation 16: 551-563.
17. Whateley, T.L., Fallon, P.A., Robertson, L., 1995, In vivo study of PLGA implants for sustained delivery of carboplatin and etoposide to the brain. Proceed. Intern. Symp. Contol. Rel. Bioact. Mater. 22: 582-583.
18. Arica, B., Kas, H.S., Orman, M.N., Hincal, A.A., 2002, Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique I. Evaluation of formulation variables on microsphere characteristics for brain delivery. J. Microencapsulation 19: 473-484.
19. Arica, B., Kas, H.S., Sargon, M.F., Acikgoz, B., Hincal, A.A., 1999, Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique II. Suitability for brain and hypophysis delivery. S.T.P. Pharma Sci. 9: 447-455.
20. Arica, B., and Kas, H.S., 1997, Beyine ilac tasinmasi. Hacettepe Tip Dergisi 28: 4-14.
21. Filipovic-Grcic, J., Maysinger, D., Zorc, B., Jalsenjak, I., 1995, Macromolecular prodrugs IV. Alginate-chitosan microspheres of PHEA-L-Dopa adduct. Int. J. Pharm. 116: 39-44.
22. Maysinger, D., Jalsenjak, V., Stolnik, S., Jalsenjak, I., 1992, Release of L-Dopa from HSA microspheres into the cat brain: in vitro and in vivo characterization by microdialysis. In Microencapsulation of Drugs (T.L. Whateley, ed), Harwood Acad. Publ., Switzerland, pp. 269-275.
23. th Int. Biomed Sci. Technol. Symp., pp. 9-11.
24. th Int. Symp. Microencapsulation p.55.
25. Yurasov, V.V., Kucheryanu, V.G., Kudrin, V.S., Zhigal-Tsev, I.V., Nikushkin, E.V., Sandalov, Y.G., Kapkin, A.P., Shvets, V.S., 1997, Effect of long term parenteral administration of empty and L-Dopa loaded liposomes on the turnover of dopamine and its metabolites in the striatum of mice with experimental Parkinson's syndrome. Bull. Exp. Biol. Med., 123: 126-129.
26. During, M.J., Freese, A., Sabel, B.A., 1989, Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann. Neuro. 25: 351-356.
27. Zhigaltsov, I.V., Kaplan, A.P., Kucheryanu, V.G., Kryzhanovsky, G.N., Kolomeichuk, S.N., Shvets, V.L., Yurasov, V.V., 2001, Liposomes containing dopamine entrapped in response to transmembrane ammonium sulphate gradient as carrier system for dopamine delivery into the brain of Parkinsonian mice. J. Liposome Res. 11: 55-71.
28. Winn, S.R., Tresco, P.A., Zielinski, B., 1991, Behavioral recovery following intrastriatal implantation of microencapsulated PC 12 cells. Exp. Neurology 113: 322-329.
29. Vallbacka, J.J., Nobrega, J.N., Sefton, M.V., 2001, Tissue engineering as a platform for controlled release of therapeutic agents: implantation of microencapsulated dopamine producing cells in the brain of rats. J. Control.Rel. 72: 93-100.
30. Howard, M.A., Gross, A., Glady, M.S., 1989, Intracerebral drug delivery in rats with lesion-induced memory deficits. J. Neurosurgery 71: 105-112.
31. Koseki, N., Takemoto, O., Sasaki, Y., 1996, A new application pf peptide drug delivery system to the brain. Proceed. Intern. Symp. Contol. Rel. Bioact. Mater. 23: 605-606.
32. Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., 1995, Passage of peptides through the blood-brain barrier with colloidal polymer nanoparticles. Brain Res. 674: 171-174.
33. Alyautdin, R. N., Tezikov, E.B., Ramge, P., Kharkevich, D. A., Begley, D. J., Kreuter, J., 1998, Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. J. Microncapsulation 15: 67-74.
34. Alyautdin, R. N., Petrov, V.E., Langer, R., Berthold, A., Kharkevich, D. A., Kreuter, J., 1997, Delivery of lorapamide across the blood-brain barrier with polysorbate 80-coated PBCA nanoparticles. Pharm. Res. 14: 324-328.
35. Fallon P.A. and Whateley, T.L., 1994, The development and evaluation of poly(lactic-glycolic acid) implants for sustained delivery of dexamethasone to the brain. Proceed. Intern. Symp. Contol. Rel. Bioact. Mater. 21: 364-365.
36. Eroglu, H., Kas, H.S., Oner, L., Turkoglu, O.F., Akalan, N., Sargon, M.F., Ozer, N., Hincal, A.A., 2000. In vitro / in vivo characterization of bovine serum albumin microspheres containing dexamethasone sodium phosphate, STP Pharm Sci. 10: 303-308.
37. Eroglu, H., Kas, H.S., Oner, L., Turkoglu, O.F., Akalan, N., Sargon, M.F., Ozer, N., 2001, The in vitro and in vivo characterization of PLGA: L-PLA microspheres containing dexamethasone sodium phosphate. J. Microencapsulation 18: 603-612.
38. Kas, H.S. and Arica, B., 1997, Delivery to brain by microparticles. Proc. Symp. Particulate Systems from Formulation to Production, pp. 123-124.